comparemela.com

Latest Breaking News On - American society of cell - Page 4 : comparemela.com

Awards & Accolades 10 May

Awards & Accolades 10 May
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Washington
United-states
American
Edwardh-ahrens-jr
Bruce-levine
Albert-maguire
David-mankoff
Samuel-jacobson
Lorraine-boakye
Gertrudem-cox
Rebeccaa-hubbard
Tjean-bennett

Alexandria Real Estate Equities, Inc. (NYSE:ARE) Q1 2023 Earnings Call Transcript

Operator: Good day, and welcome to the Alexandria Real Estate Equities First Quarter 2023 Conference Call. All participants will be in listen-only mode.

San-diego
California
United-states
Texas
Alexandria
Al-iskandariyah
Egypt
Cambridge
Cambridgeshire
United-kingdom
South-san-francisco
Maryland

Cellectis Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Cellectis Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Paris
France-general
France
North-carolina
Texas
Raleigh
China
American
Ashleyr-robinson
Monica-guzman

Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results

09.08.2022 - Patient Enrollment into BEACON Phase 1/2 Trial of BEAM-101 On-track for Second Half of 2022 BEAM-201 IND Submitted to FDA; Currently on Clinical Hold BEAM-102 IND Submission and BEAM-301 IND-enabling Studies On-track for Second Half of 2022 John .

United-states
Cambridge
Cambridgeshire
United-kingdom
American
John-evans
Dan-budwick
Astra-zeneca
Chelcie-lister
Beam-therapeutics-inc
Federation-of-american-societies-for-experimental-biology
Drug-administration

Cellectis Provides Business Update and Reports Financial Results for Second Quarter 2022

04.08.2022 -   IND clearance received from FDA for UCART20x22 for the treatment of Non-Hodgkin LymphomaCellectis unveiled novel immune-evasive universal allogeneic CAR T-cell in Nature Communications; awarded oral presentation at ASGCT in MayMr. Axel-Sven .

New-york
United-states
Paris
France-general
France
North-carolina
Raleigh
American
Ashleyr-robinson
Axel-sven-malkomes
Donald-bergstrom
Arthur-stril

vimarsana © 2020. All Rights Reserved.